CCCC
Price
$1.40
Change
-$0.12 (-7.89%)
Updated
Jun 27 closing price
Capitalization
100.82M
38 days until earnings call
FATE
Price
$1.04
Change
-$0.06 (-5.45%)
Updated
Jun 27 closing price
Capitalization
119.22M
31 days until earnings call
Interact to see
Advertisement

CCCC vs FATE

Header iconCCCC vs FATE Comparison
Open Charts CCCC vs FATEBanner chart's image
C4 Therapeutics
Price$1.40
Change-$0.12 (-7.89%)
Volume$8.25M
Capitalization100.82M
Fate Therapeutics
Price$1.04
Change-$0.06 (-5.45%)
Volume$3.75M
Capitalization119.22M
CCCC vs FATE Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. FATE commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and FATE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CCCC: $1.40 vs. FATE: $1.04)
Brand notoriety: CCCC and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 691% vs. FATE: 195%
Market capitalization -- CCCC: $100.82M vs. FATE: $119.22M
CCCC [@Biotechnology] is valued at $100.82M. FATE’s [@Biotechnology] market capitalization is $119.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while FATE’s TA Score has 2 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 6 bearish.
  • FATE’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than FATE.

Price Growth

CCCC (@Biotechnology) experienced а -1.41% price change this week, while FATE (@Biotechnology) price change was -12.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

FATE is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($119M) has a higher market cap than CCCC($101M). FATE YTD gains are higher at: -36.970 vs. CCCC (-61.111). CCCC has higher annual earnings (EBITDA): -102.74M vs. FATE (-168.28M). FATE has more cash in the bank: 240M vs. CCCC (215M). CCCC has less debt than FATE: CCCC (64.4M) vs FATE (83.3M). CCCC has higher revenues than FATE: CCCC (39.8M) vs FATE (13.3M).
CCCCFATECCCC / FATE
Capitalization101M119M85%
EBITDA-102.74M-168.28M61%
Gain YTD-61.111-36.970165%
P/E RatioN/AN/A-
Revenue39.8M13.3M299%
Total Cash215M240M90%
Total Debt64.4M83.3M77%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCFATE
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCELB314.7510.15
+3.33%
FuelCell Energy, Inc.
SHMDF149.32N/A
N/A
Shimano Inc.
SWSSF2.38N/A
N/A
Swiss Wtr Decaffinated Coffee Inc.
BRYAF0.03N/A
N/A
Berjaya Corporation BHD
WKISF30.56N/A
N/A
Workman Company Ltd.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-7.89%
KYMR - CCCC
56%
Loosely correlated
-3.48%
CRBU - CCCC
55%
Loosely correlated
-5.19%
BEAM - CCCC
53%
Loosely correlated
-1.98%
FATE - CCCC
52%
Loosely correlated
-5.45%
RXRX - CCCC
51%
Loosely correlated
-6.85%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with CRBU. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-5.45%
CRBU - FATE
58%
Loosely correlated
-5.19%
ALLO - FATE
57%
Loosely correlated
-1.67%
CRSP - FATE
56%
Loosely correlated
N/A
RXRX - FATE
55%
Loosely correlated
-6.85%
NTLA - FATE
54%
Loosely correlated
-0.52%
More